Epigral Ltd

Epigral Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Epigral Ltd

₹ 1,216 -2.57%
15 May - close price
epigral.com BSE: 543332 NSE: EPIGRAL
About

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals in India. Epigral’s Dahej facility is a backward and forward integrated and automated complex with a well-planned infrastructure.

In India, Epigral is the first to set up an Epichlorohydrin plant and largest capacity plant of CPVC Resin. Epigral is also a leading manufacturer of Caustic Soda, Caustic Potash, Chloromethanes, Hydrogen Peroxide, Chlorine and Hydrogen.

Key Points

Product Segments
a. Derivatives & Speciality Chemicals (56% in H1 FY25 vs 25% in FY22): [1] [2] The company is the 5th largest producer of Chloromethanes (CMS) in India, its CMS portfolio includes MDC, Chloroform and CTC. It is also 3rd largest producer of Hydrogen Peroxide in India. [3] It also produces specialty chemicals like CPVC Resin, CPVC compound, Epichlorohydrin, Chlorotoluenes Value Chain, etc. [4]

Website BSE NSE
  • Market Cap ₹ 5,261 Cr.
  • Current Price ₹ 1,216
  • High / Low ₹ 2,114 / 806
  • Stock P/E 15.8
  • Book Value ₹ 515
  • Dividend Yield 0.41 %
  • ROCE 15.6 %
  • ROE 16.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Tax rate seems low
  • Debtor days have increased from 42.4 to 60.2 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
562 455 478 472 525 651 626 645 628 607 587 597 736
408 360 370 349 369 475 448 463 454 443 455 494 569
Operating Profit 155 95 108 123 155 176 178 183 173 163 132 103 168
OPM % 28% 21% 23% 26% 30% 27% 28% 28% 28% 27% 22% 17% 23%
5 2 1 2 2 2 6 4 4 9 2 6 -1
Interest 19 18 21 20 14 14 27 -0 12 23 22 11 16
Depreciation 30 31 32 31 30 33 32 33 34 42 42 43 42
Profit before tax 110 47 56 74 113 131 125 154 131 107 70 55 110
Tax % 30% 34% 32% 34% 32% 34% 35% 33% 34% -50% 26% 28% 26%
77 32 38 49 77 86 81 104 87 161 51 39 81
EPS in Rs 18.47 7.58 9.14 11.81 18.60 20.67 19.57 24.02 20.14 37.25 11.87 9.07 18.76
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
829 1,551 2,188 1,929 2,550 2,527
567 1,041 1,499 1,448 1,839 1,961
Operating Profit 261 509 689 481 711 566
OPM % 32% 33% 31% 25% 28% 22%
2 4 8 7 16 15
Interest 29 44 66 73 53 72
Depreciation 74 86 109 124 133 168
Profit before tax 161 383 522 291 541 341
Tax % 37% 34% 32% 33% 34% 3%
101 253 353 196 358 332
EPS in Rs 24.48 60.84 85.03 47.14 82.91 76.95
Dividend Payout % 0% 0% 6% 11% 7% 6%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 5%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: -2%
TTM: -7%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 8%
1 Year: -34%
Return on Equity
10 Years: %
5 Years: 24%
3 Years: 18%
Last Year: 16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 42 42 42 42 43 43
Reserves 432 684 1,028 1,213 1,861 2,178
753 993 879 964 593 572
222 405 484 576 655 712
Total Liabilities 1,449 2,124 2,432 2,794 3,152 3,505
1,102 1,068 1,804 1,767 2,238 2,117
CWIP 126 589 158 483 64 451
Investments 0 0 21 21 98 23
221 467 450 524 752 915
Total Assets 1,449 2,124 2,432 2,794 3,152 3,505

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
229 284 626 398 441 436
-197 -455 -437 -401 -262 -355
-32 195 -200 -8 -164 -94
Net Cash Flow 1 24 -11 -11 15 -14
Free Cash Flow 32 -172 210 -1 254 50
CFO/OP 99% 68% 106% 93% 78% 90%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 52 60 28 34 33 60
Inventory Days 51 74 69 90 105 89
Days Payable 69 42 36 63 50 66
Cash Conversion Cycle 34 92 61 61 88 83
Working Capital Days -92 -26 -41 -54 26 16
ROCE % 29% 32% 17% 25% 16%

Insights

In beta
Mar 2010 Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Dec 2025
Installed Capacity - Caustic Soda
KTPA ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Production Volume - Chloromethanes
MT ・Standalone data
Installed Capacity - CPVC Resin
KTPA ・Standalone data
Installed Capacity - Epichlorohydrin (ECH)
KTPA ・Standalone data
Overall Plant Utilization
% ・Standalone data
Chlorine Integration level
% ・Standalone data
Electrochemical Unit (ECU) Realization
INR/MT ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
71.37% 71.38% 71.38% 71.49% 71.58% 71.58% 68.94% 68.95% 68.83% 68.83% 68.83% 68.83%
1.16% 1.14% 1.17% 1.36% 1.46% 2.10% 3.01% 3.01% 3.06% 2.71% 2.36% 1.54%
0.04% 0.04% 0.05% 0.02% 0.18% 1.17% 4.31% 4.66% 4.78% 4.93% 5.13% 4.90%
0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
27.39% 27.40% 27.37% 27.10% 26.75% 25.12% 23.71% 23.34% 23.30% 23.52% 23.67% 24.71%
No. of Shareholders 95,83395,74292,95988,87085,76183,17681,69780,87879,95178,60577,56277,583

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls